Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.

書誌詳細
主要な著者:	Bafadhel, M, Davies, L, Calverley, P, Aaron, S, Brightling, C, Pavord, I
フォーマット:	Journal article
言語:	English
出版事項:	European Respiratory Society 2014

類似資料

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
著者:: Bafadhel, M, 等
出版事項: (2016)

Inhaled glucocorticoids and COPD exacerbations.
著者:: Brightling, C, 等
出版事項: (2015)

Prednisolone response in patients with COPD.
著者:: Pavord, I, 等
出版事項: (2004)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
著者:: Shrimanker, R, 等
出版事項: (2017)

Blood eosinophil count and exacerbation risk in patients with COPD.
著者:: Kerkhof, M, 等
出版事項: (2017)

Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
著者:: Helen F. Ashdown, 等
出版事項: (2021-02-01)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
著者:: Eltboli, O, 等
出版事項: (2014)

Seasonality of eosinophilic and non-eosinophilic exacerbations of COPD
著者:: Barker, R, 等
出版事項: (2017)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
著者:: Moran, AM, 等
出版事項: (2020)

Eosinophils in COPD: just another biomarker?
著者:: Bafadhel, M, 等
出版事項: (2017)

Characterising non-eosinophilic COPD
著者:: Hambleton, K, 等
出版事項: (2015)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
著者:: Siddiqui, S, 等
出版事項: (2018)

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations
著者:: Djamin, R, 等
出版事項: (2019)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
著者:: Siddiqui SH, 等
出版事項: (2018-11-01)

Association between blood eosinophil count and risk of exacerbations in patients with COPD
著者:: Kerkhof, M, 等
出版事項: (2017)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
著者:: Siva, R, 等
出版事項: (2007)

Shall we focus on the eosinophil to guide treatment with systemic corticosteroids during acute exacerbations of COPD?: PRO
著者:: Camp, J, 等
出版事項: (2018)

Prednisolone for COPD exacerbations: time for a rethink
著者:: Sanjay Ramakrishnan
出版事項: (2023-09-01)

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of COPD?: PRO
著者:: James Camp, 等
出版事項: (2018-09-01)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
著者:: Shrimanker, R, 等
出版事項: (2017)

Modelling peripheral blood eosinophils to identify response to budesonide in COPD: a post-hoc analysis
著者:: Bafadhel, M, 等
出版事項: (2017)

Relationship Between Blood Eosinophils and Systemic Corticosteroid Therapy in COPD Exacerbation
著者:: Gong Y, 等
出版事項: (2022-09-01)

Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.
著者:: Bafadhel, M, 等
出版事項: (2012)

Investigating blood eosinophil count thresholds in patients with COPD
著者:: Russell, R, 等
出版事項: (2018)

Variability of blood eosinophil count and prognosis of COPD exacerbations
著者:: Sandra Martínez-Gestoso, 等
出版事項: (2021-01-01)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
著者:: Shrimanker, R, 等
出版事項: (2017)

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Exacerbation Endpoints
著者:: Bafadhel, M, 等
出版事項: (2018)

Peripheral blood eosinophil drop-to-drop variation in patients with COPD using near patient testing: a small validation study
著者:: Jeffers, H, 等
出版事項: (2017)

COPD exacerbations in general practice: variability in oral prednisolone courses
著者:: de Vries Marianne, 等
出版事項: (2012-01-01)

Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
著者:: Moran, A, 等
出版事項: (2020)

Evaluation of exacerbations and blood eosinophils in UK and US COPD populations
著者:: Claus F. Vogelmeier, 等
出版事項: (2019-08-01)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
著者:: Haldar, P, 等
出版事項: (2009)

Aspergillus fumigatus during stable state and exacerbations of COPD.
著者:: Bafadhel, M, 等
出版事項: (2014)

Association Between Pathogens Detected Using Quantitative Polymerase Chain Reaction With Airway Inflammation in COPD at Stable State and Exacerbations.
著者:: Barker, B, 等
出版事項: (2015)

Mepolizumab for eosinophilic COPD
著者:: Sciurba, F, 等
出版事項: (2018)

Blood eosinophil levels as a biomarker in COPD
著者:: Brusselle, G, 等
出版事項: (2018)

Copd in the ed: eosinophils, treatment and outcomes, data from the pre-award study
著者:: Russell, R, 等
出版事項: (2016)

The significance of eosinophilic inflammation in COPD
著者:: Cooper, C, 等
出版事項: (2017)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
著者:: Green, R, 等
出版事項: (2002)

Neutrophil-to-lymphocyte ratio, blood eosinophils and COPD exacerbations: a cohort study
著者:: Jens Ellingsen, 等
出版事項: (2021-12-01)